Oncotarget

Research Papers:

Development of risk prediction models for glioma based on genome-wide association study findings and comprehensive evaluation of predictive performances

Yingjie Zhao, Gong Chen, Hongjie Yu, Lingna Hu, Yunmeng Bian, Dapeng Yun, Juxiang Chen, Ying Mao, Hongyan Chen and Daru Lu _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:8311-8325. https://doi.org/10.18632/oncotarget.10882

Metrics: PDF 1892 views  |   HTML 2618 views  |   ?  


Abstract

Yingjie Zhao1,*, Gong Chen2,*, Hongjie Yu1,3, Lingna Hu1, Yunmeng Bian1, Dapeng Yun1, Juxiang Chen4, Ying Mao2,**, Hongyan Chen1,**, Daru Lu1,**

1State Key Laboratory of Genetic Engineering and MOE Key Laboratory of Contemporary Anthropology, Collaborative Innovation Center for Genetics and Development, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China

2Neurosurgery Department of Huashan Hospital, Fudan University, Shanghai, China

3Center for Genetic Epidemiology, School of Life Sciences, Fudan University, Shanghai, China

4Department of Neurosurgery, Changzheng Hospital, Second Military Medical University, Shanghai, China

*These authors have contributed equally to this work

**These authors jointly direct this work

Correspondence to:

Daru Lu, email: [email protected]

Keywords: glioma, genome wide association study, risk prediction, genetic risk score, prediction risk from logistic regression analyses

Received: October 16, 2015     Accepted: June 29, 2016     Published: July 28, 2016

ABSTRACT

Over 14 common single nucleotide polymorphisms (SNP) have been consistently identified from genome-wide association studies (GWAS) as associated with glioma risk in European background. The extent to which and how these genetic variants can improve the prediction of glioma risk has was not been investigated. In this study, we employed three independent case-control datasets in Chinese populations, tested GWAS signals in dataset1, validated association results in dataset2, developed prediction models in dataset2 for the consistently replicated SNPs, refined the consistently replicated SNPs in dataset3 and developed tailored models for Chinese populations. For model construction, we aggregated the contribution of multiple SNPs into genetic risk scores (count GRS and weighed GRS) or predicted risks from logistic regression analyses (PRFLR).

In dataset2, the area under receiver operating characteristic curves (AUC) of the 5 consistently replicated SNPs by PRFLR(SNPs) was 0.615, higher than those of all GRSs(ranging from 0.607 to 0.611, all P>0.05). The AUC of genetic profile significantly exceeded that of family history (fmc) alone (AUC=0.535, all P<0.001). The best model in our study comprised “PRURA +fmc” (AUC=0.646) in dataset3. Further model assessment analyses provided additional evidence.

This study indicates that genetic markers have potential value for risk prediction of glioma.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10882